Board of Directors

Gisela M. Schwab, President, Product Development and Medical Affairs and Chief Medical Officer, Exelixis.

Gisela Schwab, M.D., currently serves as President, Product Development and Medical Affairs and Chief Medical Officer, Exelixis. Previously, she held the position of Senior Vice President and Chief Medical Officer at Abgenix, Inc., a human antibody-based drug development company. Prior to Abgenix, Dr. Schwab held positions of increasing responsibility at Amgen Inc., most recently as Director of Clinical Research and Hematology/Oncology Therapeutic Area Team Leader. Dr. Schwab also serves as a member of the board of directors of Topotarget A/S, a publicly-held biopharmaceutical company. She received her Doctor of Medicine degree from the University of Heidelberg, trained at the University of Erlangen-Nuremberg and the National Cancer Institute and is board certified in internal medicine and hematology and oncology.

 

Copyright ©2006-2016 Cellerant Therapeutics, Inc.